These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 9163863)

  • 1. A pharmacokinetic comparison of the corn oil versus microemulsion gelcap formulation of cyclosporin used de novo after renal transplantation.
    Amante AJ; Meier-Kriesche HU; Schoenberg L; Kahan BD
    Transpl Int; 1997; 10(3):217-22. PubMed ID: 9163863
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pretransplant test-dose pharmacokinetic profiles: cyclosporine microemulsion versus corn oil-based soft gel capsule formulation.
    Chueh SC; Kahan BD
    J Am Soc Nephrol; 1998 Feb; 9(2):297-304. PubMed ID: 9527407
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral cyclosporine preparations immediately following renal transplantation.
    Katz SM; Amante A; Schoenberg L; Kahan BD
    Transplant Proc; 1996 Aug; 28(4):2164. PubMed ID: 8769188
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence for earlier stabilization of cyclosporine pharmacokinetics in de novo renal transplant patients receiving a microemulsion formulation.
    Kovarik JM; Mueller EA; Richard F; Niese D; Halloran PF; Jeffery J; Paul LC; Keown PA
    Transplantation; 1996 Sep; 62(6):759-63. PubMed ID: 8824473
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pre- and postrenal transplantation pharmacokinetics of cyclosporine microemulsion.
    Talaulikar GS; John GT; Selvakumar R; Job V; Thomas PP; Jacob CK
    Transplant Proc; 2003 Jun; 35(4):1295-7. PubMed ID: 12826141
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of bile on cyclosporin absorption from microemulsion formulation in primary liver transplant recipients.
    Winkler M; Ringe B; Oldhafer K; Kattner A; Färber L; Maibücher A; Wonigeit K; Pichlmayr R
    Transpl Int; 1995; 8(4):324-6. PubMed ID: 7546157
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of Neoral and Sandimmun for induction and maintenance immunosuppression after kidney transplantation.
    Senel FM; Yildirim S; Karakayali H; Moray G; Haberal M
    Transpl Int; 1997; 10(5):357-61. PubMed ID: 9287400
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclosporin microemulsion (Neoral). A pharmacoeconomic review of its use compared with standard cyclosporin in renal and hepatic transplantation.
    Coukell AJ; Plosker GL
    Pharmacoeconomics; 1998 Dec; 14(6):691-708. PubMed ID: 10346420
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Population pharmacokinetic model to predict steady-state exposure to once-daily cyclosporin microemulsion in renal transplant recipients.
    Schädeli F; Marti HP; Frey FJ; Uehlinger DE
    Clin Pharmacokinet; 2002; 41(1):59-69. PubMed ID: 11825097
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Concentration-guided strategies in drug development: experience with a cyclosporine analog in transplantation.
    Kovarik JM; Mueller EA; Kallay Z; Smith HT; Lison AE; Arns W; Renner E
    J Clin Pharmacol; 1995 Dec; 35(12):1136-43. PubMed ID: 8750363
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preprandial microemulsion cyclosporine administration is effective for patients with refractory nephrotic syndrome.
    Shirai S; Yasuda T; Tsuchida H; Kuboshima S; Konno Y; Shima Y; Sato T; Hatta S; Masuhara K; Kimura K
    Clin Exp Nephrol; 2009 Apr; 13(2):123-129. PubMed ID: 19057979
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduced inter- and intrasubject variability in cyclosporine pharmacokinetics in renal transplant recipients treated with a microemulsion formulation in conjunction with fasting, low-fat meals, or high-fat meals.
    Kahan BD; Dunn J; Fitts C; Van Buren D; Wombolt D; Pollak R; Carson R; Alexander JW; Choc M; Wong R
    Transplantation; 1995 Feb; 59(4):505-11. PubMed ID: 7878754
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of (1:1) cyclosporine A conversion to its microemulsion formulation on the kidney function of patients with cardiac allografts.
    Khajehdehi P; Yip D; Bastani B
    Clin Transplant; 1999 Apr; 13(2):176-80. PubMed ID: 10202614
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cyclosporin. A review of the pharmacokinetic properties, clinical efficacy and tolerability of a microemulsion-based formulation (Neoral).
    Noble S; Markham A
    Drugs; 1995 Nov; 50(5):924-41. PubMed ID: 8586033
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Equivalence of cyclosporine blood level assays in patients receiving cyclosporine microemulsion or cyclosporine. The Sandoz Neoral Study Group N103.
    Pescovitz MD; Wong RL; Choc MG; Chang CT
    Clin Transplant; 1997 Oct; 11(5 Pt 1):442-5. PubMed ID: 9361938
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cyclosporin A (Neoral) in pediatric organ transplantation. Neoral Pediatric Study Group.
    Hoyer PF
    Pediatr Transplant; 1998 Feb; 2(1):35-9. PubMed ID: 10084758
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microemulsion technology in the reformulation of cyclosporine: the reason behind the pharmacokinetic properties of Neoral.
    Ritschel WA
    Clin Transplant; 1996 Aug; 10(4):364-73. PubMed ID: 8884110
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetic conversion study of a new cyclosporine formulation in stable adult renal transplant recipients.
    Perlík F; Masri MA; Rost M; Kamarád V
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2005 Dec; 149(2):309-13. PubMed ID: 16601778
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Substitution of conventional cyclosporin with a new microemulsion formulation in renal transplant patients: results after 1 year.
    Neumayer HH; Färber L; Haller P; Kohnen R; Maibücher A; Schuster A; Vollmar J; Budde K; Waiser J; Luft FC
    Nephrol Dial Transplant; 1996 Jan; 11(1):165-72. PubMed ID: 8649628
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Absorption profiling of cyclosporine microemulsion (neoral) during the first 2 weeks after renal transplantation.
    Canadian Neoral Renal Transplantation Study Group
    Transplantation; 2001 Sep; 72(6):1024-32. PubMed ID: 11579295
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.